TOVX

Theriva Biologics Inc

$0.20

-0 (-1.4%)

Analyst Overview

Target Price:

Date: 27.02.2026

$7.00

(+3453.3%)

Strong Buy: 0

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Description:

Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. The company is headquartered in Rockville, Maryland.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850

Fiscal year end:

December

Market capitalization:

$7.13 Million

EBITDA:

-$16.5 Million

PERatio:

0.097

EPS:

2.06

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

0.569

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

29-01-2016: $13,912.50 and 30-01-2026: $0.18